Cryoablation or tumor freezing is a percutaneous, office-based procedure that is emerging as a minimally invasive, cost-effective alternative to surgery that is currently being evaluated in clinical trials for the management of for early-stage invasive breast cancer. The investigator will also evaluate the potential of cryoablation as a minimally invasive alternative to surgery for small areas of DCIS by examining its ability to achieve complete ablation of DCIS within the targeted cryoablation zone of necrosis.
DCIS spanning 2 cm or less based on its radiographic appearance by mammography and/or breast contrast-enhanced MRI Diagnosis of DCIS by minimally invasive needle biopsy No prior history of DCIS or invasive breast cancer in the same breast No history of surgical biopsy and/or lumpectomy for diagnosis/treatment in the same breast Adequate breast volume and skin clearance to permit cryoablation as assessed by Dr. Holmes. This excludes male and females with breasts too small to allow safe cryoablation Non-pregnant, non-lactating, and no history of pregnancy within the preceding 6 months No history of breast radiation in the same breast
